和邦生物（603077）(603077.SH)发布公告，经自查，公司需补缴2023年1月1日至2023年12月31日企业 所得税及滞纳金合计7147.4万元。截至本公告披露日，公司已将上述税款及滞纳金缴纳完毕，本事项不 涉及行政处罚。 公司补缴上述税款及滞纳金将计入2025年当期损益，预计将影响公司2025年度归属于上市公司股东的净 利润7147.4万元，最终以2025年度经审计的财务报表为准。 ...

Group 1 - The company has approved a total guarantee limit of up to 63 billion for wholly-owned subsidiaries, 16.6 billion for controlling subsidiaries, and 1.05 billion for joint ventures, with additional guarantees for upstream and downstream enterprises and dealers totaling 53.9 billion and 173 billion respectively [3] - In July 2025, the company increased the guarantee limit for related parties to a total of 89.4 billion [3] - The company has provided guarantees to financial companies to support product sales and enhance supply chain competitiveness, considering factors such as profitability and debt repayment ability [6] Group 2 - From April to July 2025, the total external guarantees amounted to 31.10 billion, with a repurchase responsibility of 5 billion [7] - As of the end of July 2025, the outstanding external guarantees were 85.25 billion, with a repurchase responsibility of 40.13 billion [7] - The company has no overdue guarantees, and all guarantees are within the authorized limits of the annual shareholders' meeting [8] Group 3 - The company has conducted a self-inspection and found that it needs to pay back taxes and penalties amounting to 28.83 million, which will impact the 2025 net profit [10][11] - The tax payments have been completed, and there are no administrative penalties involved [10]